Analysis | Metabolite Name | Measured Value | Units | subject type |
---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 1559044 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 1588422 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 1643203 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 1913710 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 2036400 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 2065776 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 2413703 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 2505507 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 2546515 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 2820033 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | Peak area | Healthy control | |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | Peak area | Mild disease | |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | Peak area | Severe disease | |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 1329792 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 1503557 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 1599363 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 1654027 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 1726695 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 1787949 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 1791962 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 1846439 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 1887240 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 1892034 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 1906195 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 1990048 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 2033233 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 2051504 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 2122369 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 2159470 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 2164382 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | Peak area | Severe disease | |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+NA)+ | 208037 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+NA)+ | Peak area | Healthy control | |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+NA)+ | Peak area | Mild disease | |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+NA)+ | Peak area | Severe disease |